SCIENTIFIC BACKGROUND

DMPK

Category:

Myotonic dystrophies are multisystemic diseases with an autosomal dominant inheritance pattern that represent the most common muscular dystrophies in adults. The prevalence of myotonic dystrophy type 1 (DM1) is estimated at 1:8,000. Onset of symptoms, such as myotonia characterized by delayed relaxation of a tense muscle, is most often observed in early adulthood. In addition, there is muscle weakness and fatigue, as well as dysphagia, an elongated face with poor facial expression, cataracts, diabetes mellitus, and cardiac arrythmias; in men there is early development of a bald forehead and testicular atrophy. The clinical presentation of DM1 is categorized into four partially overlapping phenotypes: asymptomatic, mild, classic, and neonatal. The congenital form is characterized by pronounced muscle hypotonia, often clubfoot formation, and is usually associated with respiratory insufficiency difficulty drinking. Psychomotor development is often delayed. This type occurs predominantly when the disease is passed down from the mother and only in DM1.

 

DM1 is caused by a CTG repeat expansion in the non-translated 3' region of the DMPK gene on chromosome 19 which encodes a protein kinase. DM2 (proximal myotonic myopathy), which is important for differential diagnosis, is caused by expansion of a CCTG repeat in intron 1 of the ZNF9 gene on chromosome 3. The phenomenon of anticipation—meaning a decrease in the age of onset of the disease and/or an increase in the severity of symptoms from one generation to the next—is particularly pronounced in DM1. Healthy individuals have 5-36 CTG repeats in the DMPK gene while DM patients have up to approximately 1,000. Children with the congenital type have more than 1,000 repeats.

 

References

Ashizawa et al. 2018, Neurol Clin Pract 8:507 / Pratte et al. 2015, Am J Med Genet A 167A:708 / Turner et al. 2010, J Neurol Neurosurg Psychiatry 81:358 / Schara et al. 2006, Semin Pediatr Neurol 13:71  / Ranum et al. 2004, Am J Hum Genet 74:793 / Larkin et al. 2001, Brain Res Bull 56:389

GENES

DMPK

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more